{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:29:28Z","timestamp":1793860168576,"version":"4.6.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"State Administration of Traditional Chinese Medicine: High-Level Key Disciplines\u2014Discipline of Traditional Chinese Medicine Pharmacy"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11659-3","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:30:15Z","timestamp":1783596615000},"page":"10091-10102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of soluble epoxide hydrolase inhibitors from natural products via structure-based virtual screening, in vitro assays, and molecular dynamics simulations"],"prefix":"10.1007","volume":"30","author":[{"given":"Zhang","family":"Liqun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Wenyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Jingyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Xiaoyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Xiaoxian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Zheming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"11659_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-014-1371-y","author":"AA El-Sherbeni","year":"2014","unstructured":"El-Sherbeni AA, El-Kadi AOS (2014) The role of epoxide hydrolases in health and disease. Arch Toxicol. https:\/\/doi.org\/10.1007\/s00204-014-1371-y. 88:2013\u20132032"},{"key":"11659_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s12033-017-9996-8","volume":"59","author":"P Saini","year":"2017","unstructured":"Saini P, Sareen D (2017) An overview on the enhancement of enantioselectivity and stability of microbial epoxide hydrolases. Mol Biotechnol 59:98\u2013116. https:\/\/doi.org\/10.1007\/s12033-017-9996-8","journal-title":"Mol Biotechnol"},{"key":"11659_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1152\/physrev.00021.2011","volume":"92","author":"JD Imig","year":"2012","unstructured":"Imig JD (2012) Epoxides and soluble epoxide hydrolase in cardiovascular physiology. Physiol Rev 92:101\u2013130. https:\/\/doi.org\/10.1152\/physrev.00021.2011","journal-title":"Physiol Rev"},{"key":"11659_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","volume":"53","author":"C Morisseau","year":"2013","unstructured":"Morisseau C, Hammock BD (2013) Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu Rev Pharmacol Toxicol 53:37\u201358. https:\/\/doi.org\/10.1146\/annurev-pharmtox-011112-140244","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"11659_CR5","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nrd2875","volume":"8","author":"JD Imig","year":"2009","unstructured":"Imig JD, Hammock BD (2009) Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discovery 8:794\u2013805. https:\/\/doi.org\/10.1038\/nrd2875","journal-title":"Nat Rev Drug Discovery"},{"key":"11659_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1517\/17460441.2014.881354","volume":"9","author":"T Duflot","year":"2014","unstructured":"Duflot T, Roche C, Lamoureux F et al (2014) Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases. Expert Opin Drug Discov 9:229\u2013243. https:\/\/doi.org\/10.1517\/17460441.2014.881354","journal-title":"Expert Opin Drug Discov"},{"key":"11659_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.prostaglandins.2013.01.002","volume":"104\u2013105","author":"JD Imig","year":"2013","unstructured":"Imig JD (2013) Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function. Prostaglandins Other Lipid mediat 104\u2013105:2\u20137. https:\/\/doi.org\/10.1016\/j.prostaglandins.2013.01.002","journal-title":"Prostaglandins Other Lipid mediat"},{"issue":"1","key":"11659_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12974-019-1635-9","volume":"16","author":"HT Lee","year":"2019","unstructured":"Lee HT, Lee KI, Chen CH, Lee TS (2019) Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer\u2019s disease. J Neuroinflamm 16(1):267. https:\/\/doi.org\/10.1186\/s12974-019-1635-9","journal-title":"J Neuroinflamm"},{"key":"11659_CR9","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.ijbiomac.2019.04.055","volume":"133","author":"ZB Liu","year":"2019","unstructured":"Liu ZB, Sun CP, Xu JX et al (2019) Phytochemical constituents from Scutellaria baicalensis in soluble epoxide hydrolase inhibition: kinetics and interaction mechanism merged with simulations. Int J Biol Macromol 133:1187\u20131193. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.04.055","journal-title":"Int J Biol Macromol"},{"key":"11659_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.compbiolchem.2018.02.019","volume":"74","author":"AB Gurung","year":"2018","unstructured":"Gurung AB, Mayengbam B, Bhattacharjee A (2018) Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis. Comput Biol Chem 74:1\u201311. https:\/\/doi.org\/10.1016\/j.compbiolchem.2018.02.019","journal-title":"Comput Biol Chem"},{"key":"11659_CR11","doi-asserted-by":"publisher","first-page":"116937","DOI":"10.1016\/j.ejmech.2024.116937","volume":"280","author":"CP Sun","year":"2024","unstructured":"Sun CP, Zhang XY, Morisseau C, Hwang SH, Zhang ZJ, Hammock BD, Ma XC (2024) Discovery of soluble epoxide hydrolase inhibitors from chemical synthesis and natural products. J Med Chem 280:116937. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116937","journal-title":"J Med Chem"},{"key":"11659_CR12","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1021\/jm201468j","volume":"55","author":"HC Shen","year":"2012","unstructured":"Shen HC, Hammock BD (2012) Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications. J Med Chem 55:1789\u20131808. https:\/\/doi.org\/10.1021\/jm201468j","journal-title":"J Med Chem"},{"key":"11659_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13321-020-00424-9","volume":"12","author":"M Sorokina","year":"2020","unstructured":"Sorokina M, Steinbeck C (2020) Review on natural products databases: where to find data in 2020. J Cheminform 12:20. https:\/\/doi.org\/10.1186\/s13321-020-00424-9","journal-title":"J Cheminform"},{"key":"11659_CR14","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1039\/d4md00389f","volume":"15","author":"H Zhang","year":"2024","unstructured":"Zhang H, Yu J, Yang Z, Guo Z et al (2024) Structure-based virtual screening discovers novel PKMYT1 inhibitors. RSC Med Chem 15:3114\u20133124. https:\/\/doi.org\/10.1039\/d4md00389f","journal-title":"RSC Med Chem"},{"key":"11659_CR15","doi-asserted-by":"publisher","first-page":"109165","DOI":"10.1016\/j.bioorg.2025.109165","volume":"166","author":"M Mustafa","year":"2025","unstructured":"Mustafa M, Alwahsh M, Hamadneh L, Hasan A, Abu-Irmaileh B (2025) Integrated virtual and experimental screening of natural products as potential anticancer agents against breast cancer. Bioorg Chem 166:109165. https:\/\/doi.org\/10.1016\/j.bioorg.2025.109165","journal-title":"Bioorg Chem"},{"key":"11659_CR16","doi-asserted-by":"publisher","first-page":"12038","DOI":"10.3390\/ijms262412038","volume":"26","author":"AH Al Khzem","year":"2025","unstructured":"Al Khzem AH, Shoaib TH, Mukhtar RM et al (2025) In silico lead identification of staphylococcus aureus LtaS inhibitors: a high-throughput computational pipeline towards prototype development. Int J Mol Sci 26:12038. https:\/\/doi.org\/10.3390\/ijms262412038","journal-title":"Int J Mol Sci"},{"key":"11659_CR17","doi-asserted-by":"publisher","first-page":"D634","DOI":"10.1093\/nar\/gkae1063","volume":"53","author":"V Chandrasekhar","year":"2025","unstructured":"Chandrasekhar V, Rajan K, Kanakam SRS, Sharma N, Wei\u00dfenborn V, Schaub J, Steinbeck C (2025) COCONUT 2.0: a comprehensive overhaul and curation of the collection of open natural products database. Nucleic Acids Res 53:D634\u2013D643. https:\/\/doi.org\/10.1093\/nar\/gkae1063","journal-title":"Nucleic Acids Res"},{"key":"11659_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221\u2013234. https:\/\/doi.org\/10.1007\/s10822-013-9644-8","journal-title":"J Comput Aided Mol Des"},{"key":"11659_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3\u201325. https:\/\/doi.org\/10.1016\/s0169-409x(00)00129-0","journal-title":"Adv Drug Deliv Rev"},{"key":"11659_CR20","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/jm901137j","volume":"53","author":"JB Baell","year":"2010","unstructured":"Baell JB, Holloway GA (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53:2719\u20132740. https:\/\/doi.org\/10.1021\/jm901137j","journal-title":"J Med Chem"},{"key":"11659_CR21","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739\u20131749. https:\/\/doi.org\/10.1021\/jm0306430","journal-title":"J Med Chem"},{"key":"11659_CR22","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"11659_CR23","first-page":"82","volume":"40","author":"WL DeLano","year":"2002","unstructured":"DeLano WL (2002) Pymol: An open-source molecular graphics tool. CCP4 Newsl protein crystallogr 40:82\u201392","journal-title":"CCP4 Newsl protein crystallogr"},{"key":"11659_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/protein\/8.2.127","volume":"8","author":"AC Wallace","year":"1995","unstructured":"Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng Des selection 8:127\u2013134. https:\/\/doi.org\/10.1093\/protein\/8.2.127","journal-title":"Protein Eng Des selection"},{"key":"11659_CR25","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski RA, Swindells MB (2011) LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery. J Chem Inf Model 51:2778\u20132786. https:\/\/doi.org\/10.1021\/ci200227u","journal-title":"J Chem Inf Model"},{"key":"11659_CR26","doi-asserted-by":"publisher","first-page":"W463","DOI":"10.1093\/nar\/gkaf361","volume":"53","author":"P Schake","year":"2025","unstructured":"Schake P, Bolz SN, Linnemann K, Schroeder M (2025) PLIP 2025: introducing protein\u2013protein interactions to the protein\u2013ligand interaction profiler. Nucleic Acids Res 53:W463\u2013W465. https:\/\/doi.org\/10.1093\/nar\/gkaf361","journal-title":"Nucleic Acids Res"},{"key":"11659_CR27","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ijbiomac.2021.04.187","volume":"183","author":"WY Zhao","year":"2021","unstructured":"Zhao WY, Zhang XY, Zhou MR et al (2021) Natural soluble epoxide hydrolase inhibitors from Alisma orientale and their potential mechanism with soluble epoxide hydrolase. Int J Biol Macromol 183:811\u2013817. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.04.187","journal-title":"Int J Biol Macromol"},{"key":"11659_CR28","doi-asserted-by":"publisher","first-page":"104065","DOI":"10.1016\/j.bioorg.2020.104065","volume":"102","author":"WY Zhao","year":"2020","unstructured":"Zhao WY, Luan ZL, Liu TT, Ming et al (2020) Inula japonica ameliorated bleomycin-induced pulmonary fibrosis via inhibiting soluble epoxide hydrolase. Bioorg Chem 102:104065. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104065","journal-title":"Bioorg Chem"},{"key":"11659_CR29","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ (2005) GROMACS: fast, flexible, and free. J Comput Chem 26:1701\u20131718. https:\/\/doi.org\/10.1002\/jcc.20291","journal-title":"J Comput Chem"},{"key":"11659_CR30","doi-asserted-by":"publisher","first-page":"082503","DOI":"10.1063\/5.0216272","volume":"161","author":"T Lu","year":"2024","unstructured":"Lu T (2024) A comprehensive electron wavefunction analysis toolbox for chemists, Multiwfn. J Chem Phys 161:082503. https:\/\/doi.org\/10.1063\/5.0216272","journal-title":"J Chem Phys"},{"key":"11659_CR31","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/jcc.22885","volume":"33","author":"T Lu","year":"2012","unstructured":"Lu T, Chen F (2012) Multiwfn: a multifunctional wavefunction analyzer. J Comput Chem 33:580\u2013592. https:\/\/doi.org\/10.1002\/jcc.22885","journal-title":"J Comput Chem"},{"key":"11659_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1021\/ci020055f","volume":"43","author":"Y Pan","year":"2003","unstructured":"Pan Y, Huang N, Cho S, Mackerell AD (2003) Consideration of molecular weight during compound selection in virtual target-based database screening. J Chem Inf Comput Sci 43:267\u2013272. https:\/\/doi.org\/10.1021\/ci020055f","journal-title":"J Chem Inf Comput Sci"},{"key":"11659_CR33","doi-asserted-by":"publisher","first-page":"e70164","DOI":"10.1111\/cbdd.70164","volume":"106","author":"VD Nimbarte","year":"2025","unstructured":"Nimbarte VD, Sonak SS, Ishwarkar SA, Rathod B, Nehlani S (2025) Novel triazole-linked indole derivatives as potent soluble epoxy hydrolase inhibitors with promising anticancer activity. Chem Biol Drug Des 106:e70164. https:\/\/doi.org\/10.1111\/cbdd.70164","journal-title":"Chem Biol Drug Des"},{"key":"11659_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1533\/9780857099921.2.126","volume-title":"Enzymes","author":"T Palmer","year":"2011","unstructured":"Palmer T, Bonner PL (2011) 8\u2014Enzyme Inhibition. In: Palmer T, Bonner PL (eds) Enzymes, 2nd edn. Woodhead Publishing, Sawston, UK, pp 126\u2013152","edition":"2"},{"key":"11659_CR35","doi-asserted-by":"publisher","first-page":"14450","DOI":"10.1039\/c7cp07623a","volume":"20","author":"H Sun","year":"2018","unstructured":"Sun H, Duan L, Chen F, Liu H et al (2018) Assessing the performance of MM\/PBSA and MM\/GBSA methods. 7. Entropy effects on the performance of end-point binding free energy calculation approaches. Phys Chem Chem Phys 20:14450\u201314460. https:\/\/doi.org\/10.1039\/c7cp07623a","journal-title":"Phys Chem Chem Phys"},{"key":"11659_CR36","doi-asserted-by":"publisher","first-page":"12027","DOI":"10.1021\/acs.jpcb.4c06614","volume":"128","author":"B Roux","year":"2024","unstructured":"Roux B, Chipot C (2024) Editorial guidelines for computational studies of ligand binding using MM\/PBSA and MM\/GBSA approximations wisely. J Phys Chem B 128:12027\u201312029. https:\/\/doi.org\/10.1021\/acs.jpcb.4c06614","journal-title":"J Phys Chem B"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11659-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11659-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11659-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:05:15Z","timestamp":1793858715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11659-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["11659"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11659-3","relation":{"references":[{"id-type":"doi","id":"10.1007\/s00204-014-1371-y","asserted-by":"subject"}]},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"8 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}